Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CRHBP | P24387 | 1/20 | 0.52 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3345446 | 0.91 | DRD2 (0.58) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL9335745 | 0.90 | PTGS2 (0.68) | MAPTALDH1A1PTGS2PTGS1KDM4E | |
| SCHEMBL9335748 | 0.90 | PTGS2 (0.68) | MAPTALDH1A1PTGS2PTGS1KDM4E | |
| SCHEMBL9174886 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL31573176 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL31573181 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL31410110 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL7162702 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL31573185 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 | |
| SCHEMBL28180218 | 0.90 | MAPT (0.56) | MAPTKCNH2DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112979397-B | Energy-containing adhesive based on three-dimensional photo-curing and preparation method thereof | 辽宁省轻工科学研究院有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-111978553-B | Triple-stimulus responsive interfacial crosslinked polymer micelle and preparation method and application thereof | 陕西师范大学 | 2021-09-14 | — | — | CN | claimed |
| CN-111471185-B | Triple-stimulus-responsive block polymer micelle and preparation method and application thereof | 陕西师范大学 | 2021-09-14 | — | — | CN | claimed |
| CN-112979397-A | Energy-containing adhesive based on three-dimensional photocuring and preparation method thereof | 辽宁省轻工科学研究院有限公司 | 2021-06-18 | — | — | CN | claimed |
| CN-111978553-A | Triple-stimulus responsive interfacial crosslinked polymer micelle and preparation method and application thereof | 陕西师范大学 | 2020-11-24 | — | — | CN | claimed |
| CN-111471185-A | Triple-stimulus-responsive block polymer micelle and preparation method and application thereof | 陕西师范大学 | 2020-07-31 | — | — | CN | claimed |
| JP-11307398-A | — | — | None | — | — | JP | disclosed |
| US-20250257069-A1 | JAK INHIBITOR ANALOGS, FORMULATIONS, AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-08-14 | — | — | US | disclosed |
| EP-4561999-A1 | TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY | Abbvie Operations Singapore Pte. Ltd. (SG) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025097020-A1 | PROCESS FOR POLYETHYLENE GLYCOL SYNTHESIS | Design Therapeutics, Inc. (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119923257-A | JAK inhibitor analogues, formulations and uses thereof | 密歇根大学董事会 | 2025-05-02 | — | — | CN | disclosed |
| CN-119923391-A | Targeted protein degradation of PARP14 for use in therapy | 艾伯维新加坡运营私人有限公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025079518-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-04-17 | — | — | WO | disclosed |
| US-4277559-A | FOR MASKING UNWANTED BLUE ABSORPTION OF MAGENTA DYES WITHOUT PRODUCING EXCESSIVE FOG | AGFA-GEVAERT N.V. (BE) | 1981-07-07 | — | — | US | disclosed |
| EP-0028331-A1 | Process for preparing urethanes | BAYER AG (DE) | 1981-05-13 | — | — | EP | disclosed |
| EP-0027952-A1 | Process for preparing N,O-disubstituted urethanes | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
| EP-0027940-A1 | Process for preparing urethanes | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
| EP-0027953-A1 | Process for preparing N,O-disubstituted urethanes | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
| US-4138258-A | NONDIFFUSING CYAN COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4024159-A | Process for the production of liquid acetals | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257069-A1 | JAK INHIBITOR ANALOGS, FORMULATIONS, AND USES THEREOF | JAK1, JAK3, JAK2 | MAPT 2679/4885KCNH2 4532/4885DRD2 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.